Related references
Note: Only part of the references are listed.Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in mdx mice
Satvik Mareedu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2021)
Nothing Regular about the Regulins: Distinct Functional Properties of SERCA Transmembrane Peptide Regulatory Subunits
Nishadh Rathod et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Uncoupling of sarcoendoplasmic reticulum calcium ATPase pump activity by sarcolipin as the basis for muscle non-shivering thermogenesis
Naresh C. Bal et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2020)
Intracellular calcium leak as a therapeutic target for RYR1-related myopathies
Alexander Kushnir et al.
ACTA NEUROPATHOLOGICA (2020)
Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline
Jonathan R. Volpatti et al.
ELIFE (2020)
Live-Cell Cardiac-Specific High-Throughput Screening Platform for Drug-Like Molecules That Enhance Ca2+ Transport
Tory M. Schaaf et al.
CELLS (2020)
Adaptive thermogenesis enhances the life-threatening response to heat in mice with an Ryr1 mutation
Hui J. Wang et al.
NATURE COMMUNICATIONS (2020)
Structural dynamics of P-type ATPase ion pumps
Mateusz Dyla et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
Restoration of SERCA ATPase prevents oxidative stress-related muscle atrophy and weakness
Rizwan Qaisar et al.
REDOX BIOLOGY (2019)
Role of defective Ca2+ signaling in skeletal muscle weakness: Pharmacological implications
Akanksha Agrawal et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches
Tokunbor A. Lawal et al.
NEUROTHERAPEUTICS (2018)
Red-Shifted FRET Biosensors for High-Throughput Fluorescence Lifetime Screening
Tory M. Schaaf et al.
BIOSENSORS-BASEL (2018)
High-Throughput Screens to Discover Small-Molecule Modulators of Ryanodine Receptor Calcium Release Channels
Robyn T. Rebbeck et al.
SLAS DISCOVERY (2017)
An Innovative High-Throughput Screening Approach for Discovery of Small Molecules That Inhibit TNF Receptors
Chih Hung Lo et al.
SLAS DISCOVERY (2017)
Small Molecular Allosteric Activator of the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) Attenuates Diabetes and Metabolic Disorders
Soojeong Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Gene therapy for the treatment of heart failure: promise postponed
Jean-Sebastien Hulot et al.
EUROPEAN HEART JOURNAL (2016)
Why Calcium? How Calcium Became the Best Communicator
Ernesto Carafoli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis
Larissa Lipskaia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Dysregulation of calcium homeostasis in muscular dystrophies
Ainara Vallejo-Illarramendi et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2014)
Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend
Kobra Haghighi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging
Alisa Umanskaya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Discovery of Enzyme Modulators via High-Throughput Time-Resolved FRET in Living Cells
Simon J. Gruber et al.
JOURNAL OF BIOMOLECULAR SCREENING (2014)
Complementary Genomic Screens Identify SERCA as a Therapeutic Target in NOTCH1 Mutated Cancer
Giovanni Roti et al.
CANCER CELL (2013)
High-Throughput FRET Assay Yields Allosteric SERCA Activators
Razvan L. Cornea et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Structural and Functional Dynamics of an Integral Membrane Protein Complex Modulated by Lipid Headgroup Charge
Ji Li et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Ryanodine Receptor Oxidation Causes Intracellular Calcium Leak and Muscle Weakness in Aging
Daniel C. Andersson et al.
CELL METABOLISM (2011)
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure
Mariell Jessup et al.
CIRCULATION (2011)
Calcium Cycling Proteins and Their Association With Heart Failure
L. Hadri et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
RYR1 Mutations Are a Common Cause of Congenital Myopathies with Central Nuclei
J. M. Wilmshurst et al.
ANNALS OF NEUROLOGY (2010)
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Frank Lovering et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Increased FOG-2 in Failing Myocardium Disrupts Thyroid Hormone-Dependent SERCA2 Gene Transcription
Rosanne Rouf et al.
CIRCULATION RESEARCH (2008)
Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts
DM Bers et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
Direct detection of calmodulin tuning by ryanodine receptor channel targets using a Ca2+-sensitive acrylodan-labeled calmodulin
BR Fruen et al.
BIOCHEMISTRY (2005)
Thermogenesis and energy expenditure:: Control of heat production by the Ca2+-ATPase of fast and slow muscle
M Reis et al.
MOLECULAR MEMBRANE BIOLOGY (2002)
Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery
M Hoshijima et al.
NATURE MEDICINE (2002)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Reduced level of serine16 phosphorylated phospholamban in the failing rat myocardium:: a major contributor to reduced SERCA2 activity
JB Sande et al.
CARDIOVASCULAR RESEARCH (2002)